U.S. market Open. Closes in 1 hour 1 minute

FBLG | FibroBiologics, Inc. Common Stock Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
RevenueN/AN/AN/AN/A
Cost of Revenue437.00K94.00KN/AN/A
Gross Profit-437.00K-94.00KN/AN/A
Operating Expenses8.89M4.37M1.58M1.17M
Selling, General & Admin6.52M3.23M1.06M500.00K
Research & Development2.37M1.15M521.00K669.00K
Other Operating ExpensesN/AN/AN/AN/A
Operating Income-8.89M-4.47M-1.58M-1.17M
Other Expenses / Income-7.60M-654.00K-4.00KN/A
Before Tax Income-16.48M-5.12M-1.58M-1.17M
Income Tax ExpensesN/AN/AN/AN/A
Net Income-16.48M-5.12M-1.58M-1.17M
Interest Expenses147.00K654.00K4.00KN/A
Basic Shares Outstanding32.49M32.49M32.49M8.75M
Diluted Shares Outstanding28.23M32.49M32.49M8.75M
EBITDA-15.90M-4.37M-1.58MN/A
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT-16.34M-4.47M-1.58M-1.17M
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙